Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00331552
Status:
COMPLETED
Last Update Posted:
2017-07-26
First Post:
2006-05-30
Brief Title:
Doxorubicin Hydrochloride Liposome Cyclophosphamide and Trastuzumab in Treating Patients With Stage IV Breast Cancer
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Breast Cancer |
| HER2-positive Breast Cancer |
| Male Breast Cancer |
| Recurrent Breast Cancer |
Keywords: